| Symbol | ADOCY |
|---|---|
| Name | ADOCIA ACT |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | 69003 France 115 avenue Lacassagne |
| Telephone | +33 (0)4 72 610 610 |
| Fax | — |
| — | |
| Website | http://www.adocia.com |
| Incorporation | FR |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Euronext Paris |
| CIK | 0001605864 |
| Description | ADOCIA is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic agents Additional info from OTC: |
No news found.